BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Therapeutics Acquisition Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 7:58 pm Sale | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | BIOTECHNOLOGY VALUE FUND L P | 954,996 6.800% | -45,004 (-4.50%) | Filing |